Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26917
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ray, Jason C | - |
dc.contributor.author | Hutton, Elspeth J | - |
dc.contributor.author | Matharu, Manjit | - |
dc.date | 2021-06-29 | - |
dc.date.accessioned | 2021-07-05T06:10:17Z | - |
dc.date.available | 2021-07-05T06:10:17Z | - |
dc.date.issued | 2021-06-29 | - |
dc.identifier.citation | Journal of Clinical Medicine 2021; 10(13): 2898 | en |
dc.identifier.issn | 2077-0383 | |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/26917 | - |
dc.description.abstract | The efficacy of onabotulinumtoxinA (OnaB-A) as a preventative treatment for chronic migraine, emerging fortuitously from clinical observation is now supported by class one evidence and over two decades of real-world clinical data. There is still limited ability to predict a clinically meaningful response to OnaB-A for individual patients, however. This review summarises briefly the proposed mechanism of OnaB-A in chronic migraine, the literature of predictors of clinical response, and recent developments in the field. | en |
dc.language.iso | eng | |
dc.subject | botulinum toxin | en |
dc.subject | migraine | en |
dc.subject | predictors of efficacy | en |
dc.title | OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Journal of Clinical Medicine | en |
dc.identifier.affiliation | The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK | en |
dc.identifier.affiliation | Department of Neurology, Alfred Hospital, Melbourne, VIC 3004, Australia | en |
dc.identifier.affiliation | Neurology | en |
dc.identifier.affiliation | Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia | en |
dc.identifier.affiliation | Headache and Facial Pain Group, University College London (UCL) Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK | en |
dc.identifier.doi | 10.3390/jcm10132898 | en |
dc.type.content | Text | en |
dc.identifier.orcid | 0000-0003-4833-5507 | en |
dc.identifier.orcid | 0000-0002-8543-7767 | en |
dc.identifier.orcid | 0000-0002-4960-2294 | en |
dc.identifier.pubmedid | 34209849 | |
local.name.researcher | Ray, Jason C | |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Neurology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.